It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
Precision Medicine implies a deep understanding of inter-individual differences in health and disease that are due to genetic and environmental factors. To acquire such understanding there is a need for the implementation of different types of technologies based on artificial intelligence (AI) that enable the identification of biomedically relevant patterns, facilitating progress towards individually tailored preventative and therapeutic interventions. Despite the significant scientific advances achieved so far, most of the currently used biomedical AI technologies do not account for bias detection. Furthermore, the design of the majority of algorithms ignore the sex and gender dimension and its contribution to health and disease differences among individuals. Failure in accounting for these differences will generate sub-optimal results and produce mistakes as well as discriminatory outcomes. In this review we examine the current sex and gender gaps in a subset of biomedical technologies used in relation to Precision Medicine. In addition, we provide recommendations to optimize their utilization to improve the global health and disease landscape and decrease inequalities.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details



1 Barcelona Supercomputing Center (BSC), Barcelona, Spain (GRID:grid.10097.3f) (ISNI:0000 0004 0387 1602)
2 Telefonica Innovation Alpha Health, Torre Telefonica, Barcelona, Spain (GRID:grid.10097.3f); The Women’s Brain Project (WBP), Guntershausen, Switzerland (GRID:grid.508244.f)
3 The Women’s Brain Project (WBP), Guntershausen, Switzerland (GRID:grid.508244.f); Wega Informatik AG, Basel, Switzerland (GRID:grid.508244.f)
4 Research Programme on Biomedical Informatics (GRIB), Hospital del Mar Research Institute and Pompeu Fabra University, Barcelona, Spain (GRID:grid.5612.0) (ISNI:0000 0001 2172 2676)
5 Eurecat - Centre Tecnològic de Catalunya, Barcelona, Spain (GRID:grid.5612.0); eHealth Center, Universitat Oberta de Catalunya, Barcelona, Spain (GRID:grid.36083.3e) (ISNI:0000 0001 2171 6620)
6 The Women’s Brain Project (WBP), Guntershausen, Switzerland (GRID:grid.508244.f)
7 Barcelona Supercomputing Center (BSC), Barcelona, Spain (GRID:grid.10097.3f) (ISNI:0000 0004 0387 1602); ICREA, Barcelona, Spain (GRID:grid.425902.8) (ISNI:0000 0000 9601 989X)
8 The Women’s Brain Project (WBP), Guntershausen, Switzerland (GRID:grid.508244.f); Interactive Robots and Media Laboratory (IRML), Abu Dhabi, United Arab Emirates (GRID:grid.508244.f)